Sugi Predict

Sugi Predict / Compounds / SCHEMBL29404708

SCHEMBL29404708

SCHEMBL29404708

C[C@H]1C[C@@]23CC[C@H]4C(C)(C)CCC[C@]4(C)[C@@H]2CC[C@H]1C3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 5/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HSD11B1 P28845 3/20 0.37
▸ IDO1 P14902 2/20 0.36
▸ HSD11B2 P80365 1/20 0.36
▸ F10 P00742 2/20 0.35
▸ CYP19A1 P11511 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HIF1A Q16665 1/20 0.32
▸ EPAS1 Q99814 1/20 0.32
▸ ENTPD5 O75356 1/20 0.32
▸ NR1H4 Q96RI1 1/20 0.32
▸ RPS6KA5 O75582 1/20 0.32
▸ MAPKAPK2 P49137 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3513520 0.82 HSD11B1 (0.57) PTPN1ALDH1A1CYP3A4HSD11B1HSD11B2
SCHEMBL17027695 0.82 HSD11B1 (0.57) PTPN1ALDH1A1CYP3A4HSD11B1HSD11B2
SCHEMBL4927656 0.81 PTPN1 (0.38) PTPN1HSD11B1IDO1HSD11B2F10
SCHEMBL4927657 0.81 PTPN1 (0.38) PTPN1HSD11B1IDO1HSD11B2F10
SCHEMBL2021014 0.80 PTPN1 (0.59) PTPN1CYP2C9HSD11B1F10MEN1
SCHEMBL2021012 0.80 PTPN1 (0.59) PTPN1CYP2C9HSD11B1F10MEN1
SCHEMBL3494203 0.80 PTPN1 (0.47) PTPN1ALDH1A1CYP3A4CYP2C9TSHR
SCHEMBL2398561 0.80 PTPN1 (0.47) PTPN1ALDH1A1CYP3A4CYP2C9TSHR
SCHEMBL31676710 0.80 PTPN1 (0.45) PTPN1ALDH1A1CYP3A4CYP2C9TSHR
SCHEMBL13401501 0.80 PTPN1 (0.47) PTPN1ALDH1A1CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250360100-A1 ANTI-CANCER DERIVATIVES OF OVATODIOLIDE AND USE THEREOF Arjil Biotech Holding Company Limited (TW) 2025-11-27 — — US disclosed
WO-2025244951-A1 ANTI-CANCER DERIVATIVES OF OVATODIOLIDE AND USE THEREOF Arjil Biotech Holding Company Limited (TW) 2025-11-27 — — WO disclosed
US-20250011735-A1 RECOMBINANT POLYPRENOL DIPHOSPHATE SYNTHASES CB THERAPEUTICS, INC. (US) 2025-01-09 — — US disclosed
US-20240124905-A1 Recombinant Polyprenol Diphosphate Synthases CB THERAPEUTICS INC (US) 2024-04-18 — — US disclosed
WO-2022164870-A1 RECOMBINANT POLYPRENOL DIPHOSPHATE SYNTHASES CB THERAPEUTICS, INC. (US) 2022-08-04 — — WO disclosed
CN-215913075-U Trunk borer hole pesticide applying device for preventing and treating longicorn larvae 沈阳工学院 2022-03-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360100-A1 ANTI-CANCER DERIVATIVES OF OVATODIOLIDE AND USE THEREOF TP53, API5, BAD PTPN1 3109/4885ALDH1A1 497/4885CYP3A4 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.